A phase II study of liposomal doxorubicin, vincristine and dexamethasone in multiple myeloma.
Hönemann
Dirk
D
Prince
H Miles
HM
Seymour
John F
JF
Wolf
Max M
MM
Westerman
David
D
Januszewicz
E Henry
EH
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003907:Dexamethasone / Q000008:administration & dosage*; D018572:Disease-Free Survival; D004317:Doxorubicin / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000401:mortality; D033581:Stem Cell Transplantation; D013997:Time Factors; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage*
D014750:Vincristine; D003907:Dexamethasone; D004317:Doxorubicin